SEC Says BioChemics Is Unable To Pay $17M Bill To Investors
Enough is enough, counsel for the U.S. Securities and Exchange Commission told a Massachusetts federal judge Wednesday in a letter insisting three years was ample time for BioChemics Inc. to find...To view the full article, register now.
Already a subscriber? Click here to view full article